New resource for selecting best treatment path for young children with cancerous tumors published by NCCN

March 8, 2024
New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types of pediatric solid tumors; includes vanguard treatment recommendations involving multimodality treatment for high-risk disease.

The National Comprehensive Cancer Network (NCCN) published a set of treatment recommendations pertaining to neuroblastoma.

There are now 87 different NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), covering nearly every type of cancer, plus screening, prevention, and supportive care. The NCCN Guidelines for Neuroblastoma are the 6th to focus specifically on treating pediatric cancer.     

NCCN also publishes NCCN Guidelines for Adolescent and Young Adult Oncology, which provide treatment advice geared toward younger populations across all cancer types. There are separate NCCN Guidelines for Survivorship that include additional information on mitigating the long-term impact of treatment.

NCCN release on Newswise

By Rawpixel.com on Adobe Stock
adobestock_137153252
By Jesse B/peopleimages.com on Adobe Stock
adobestock_557096555
By Pixel-Shot on Adobe Stock
adobestock_224306882
ID 310202522 © Oleksandra Tsvid | Dreamstime.com
dreamstime_xxl_310202522_2